Malcolm K. Brenner

1.6k total citations · 1 hit paper
16 papers, 1.3k citations indexed

About

Malcolm K. Brenner is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Malcolm K. Brenner has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Immunology and 5 papers in Genetics. Recurrent topics in Malcolm K. Brenner's work include Virus-based gene therapy research (5 papers), Viral-associated cancers and disorders (5 papers) and CAR-T cell therapy research (4 papers). Malcolm K. Brenner is often cited by papers focused on Virus-based gene therapy research (5 papers), Viral-associated cancers and disorders (5 papers) and CAR-T cell therapy research (4 papers). Malcolm K. Brenner collaborates with scholars based in United States, United Kingdom and Switzerland. Malcolm K. Brenner's co-authors include Cliona M. Rooney, Robert A. Krance, Susan K. Loftin, Helen E. Heslop, Catherine Y. Ng, Martha Holladay, Catherine M. Bollard, Claudia Rössig, Jed G. Nuchtern and Fernando Siller-López and has published in prestigious journals such as Nature Medicine, International Journal of Cancer and Transplantation.

In The Last Decade

Malcolm K. Brenner

16 papers receiving 1.3k citations

Hit Papers

Long–term restoration of immunity against Epstein–Barr vi... 1996 2026 2006 2016 1996 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm K. Brenner United States 13 902 545 489 312 204 16 1.3k
Yan‐jun Gan United States 9 1.1k 1.2× 526 1.0× 571 1.2× 237 0.8× 96 0.5× 11 1.4k
Martha Holladay United States 19 679 0.8× 744 1.4× 262 0.5× 370 1.2× 330 1.6× 21 1.4k
Pauline Meij Netherlands 21 782 0.9× 500 0.9× 381 0.8× 195 0.6× 237 1.2× 48 1.3k
Andreas Moosmann Germany 24 1.3k 1.4× 1.0k 1.8× 830 1.7× 195 0.6× 378 1.9× 54 2.1k
Ken‐Ichi Imadome Japan 22 859 1.0× 606 1.1× 330 0.7× 93 0.3× 188 0.9× 103 1.4k
Marie Roskrow Germany 14 546 0.6× 513 0.9× 174 0.4× 129 0.4× 140 0.7× 24 873
Clare Taylor United States 8 751 0.8× 356 0.7× 204 0.4× 201 0.6× 207 1.0× 15 942
Deanna M. Grote United States 13 546 0.6× 698 1.3× 225 0.5× 365 1.2× 212 1.0× 23 1.4k
Sebastian Tuve United States 20 682 0.8× 440 0.8× 197 0.4× 633 2.0× 606 3.0× 25 1.3k
Yanto Lunardi-Iskandar United States 15 408 0.5× 281 0.5× 138 0.3× 167 0.5× 311 1.5× 27 947

Countries citing papers authored by Malcolm K. Brenner

Since Specialization
Citations

This map shows the geographic impact of Malcolm K. Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm K. Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm K. Brenner more than expected).

Fields of papers citing papers by Malcolm K. Brenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm K. Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm K. Brenner. The network helps show where Malcolm K. Brenner may publish in the future.

Co-authorship network of co-authors of Malcolm K. Brenner

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm K. Brenner. A scholar is included among the top collaborators of Malcolm K. Brenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm K. Brenner. Malcolm K. Brenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Gahn, B., Fernando Siller-López, Eric Yvon, et al.. (2001). Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma. International Journal of Cancer. 93(5). 706–713. 65 indexed citations
3.
Rössig, Claudia, et al.. (2001). Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes. International Journal of Cancer. 94(2). 228–236. 122 indexed citations
4.
Heslop, Helen E., et al.. (1999). Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant. Journal of Clinical Apheresis. 14(3). 154–156. 22 indexed citations
5.
Bowman, Laura C., Michael E. Grossmann, Donna Rill, et al.. (1998). Interleukin-2 Gene-Modified Allogeneic Tumor Cells for Treatment of Relapsed Neuroblastoma. Human Gene Therapy. 9(9). 1303–1311. 60 indexed citations
6.
Heslop, Helen E., Catherine Y. Ng, Susan K. Loftin, et al.. (1996). Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes. Nature Medicine. 2(5). 551–555. 668 indexed citations breakdown →
7.
Smith, Colton A., et al.. (1996). Adoptive Immunotherapy for Epstein-Barr Virus-Related Lymphoma. Leukemia & lymphoma. 23(3-4). 213–220. 23 indexed citations
8.
Rooney, Cliona M., et al.. (1995). Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative disease. British Journal of Haematology. 89(1). 98–103. 193 indexed citations
9.
Blaese, Michael, Thomas Blankenstein, Malcolm K. Brenner, et al.. (1995). Vectors in cancer therapy: how will they deliver?. PubMed. 2(4). 291–7. 47 indexed citations
10.
Brenner, Malcolm K.. (1994). 6 Haematological applications of interleukin-2 and other immunostimulatory cytokines. Baillière s Clinical Haematology. 7(1). 115–134. 2 indexed citations
11.
Ellerson, Debra, Soon‐Pal Suh, David F. Claxton, et al.. (1992). Use of Cell-Free Retroviral Vector Preparations for Transduction of Cells from the Marrow of Chronic Phase and Blast Crisis Chronic Myelogenous Leukemia Patients and from Normal Individuals. Human Gene Therapy. 3(2). 137–145. 17 indexed citations
12.
Gottlieb, David, H. G. Prentice, Atul Mehta, et al.. (1990). Malignant plasma cells are sensitive to LAK cell lysis: pre‐clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma. British Journal of Haematology. 75(4). 499–505. 27 indexed citations
13.
Buschle, Michael, Malcolm K. Brenner, Irvin S. Y. Chen, et al.. (1990). Transfection and gene expression in normal and malignant primary B lymphocytes. Journal of Immunological Methods. 133(1). 77–85. 21 indexed citations
14.
Reittie, Joyce E., H. G. Prentice, Hans G. Drexler, et al.. (1988). DIFFERENTIAL RECOVERY OF PHENOTYPICALLY AND FUNCTIONALLY DISTINCT CIRCULATING ANTIGEN-PRESENTING CELLS AFTER ALLOGENEIC MARROW TRANSPLANTATION. Transplantation. 45(6). 1084–1090. 9 indexed citations
15.
Prentice, Grant & Malcolm K. Brenner. (1987). Bone Marrow Transplantation in Acute or Chronic Leukaemia. Acta Haematologica. 78(1). 194–197. 2 indexed citations
16.
Brenner, Malcolm K. & Alan Munro. (1981). Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes.. PubMed. 46(1). 171–7. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026